- Q4 2023 Medivir AB Earnings Call TranscriptFeb 15, 2024kr2.97 (+3.31%)Earnings
- Medivir AB to Discuss the Updated Data in Advanced Hepatocellular Carcinoma Call TranscriptJan 23, 2024
- Q3 2023 Medivir AB Earnings Call TranscriptOct 27, 2023kr5.73 (-10.26%)Earnings
- Q2 2023 Medivir AB Earnings Call TranscriptAug 18, 2023kr6.06 (-1.29%)Earnings
- Q1 2023 Medivir AB Earnings Call TranscriptApr 27, 2023kr6.11Earnings
- Q4 2022 Medivir AB Earnings Call TranscriptFeb 15, 2023kr7.05 (-3.37%)Earnings
- Medivir AB at Redeye Fight Cancer Day (Virtual) TranscriptJan 19, 2023
- Q3 2022 Medivir AB Earnings Call TranscriptNov 03, 2022kr6.61 (+0.75%)Earnings
- Q2 2022 Medivir AB Earnings Call TranscriptAug 19, 2022kr6.67 (+3.83%)Earnings
- Q1 2022 Medivir AB Earnings Call TranscriptApr 28, 2022kr6.54 (+1.01%)Earnings
- Q4 2021 Medivir AB Earnings Call TranscriptFeb 15, 2022kr6.84 (+1.21%)Earnings
- Q3 2021 Medivir AB Earnings Call TranscriptNov 03, 2021kr7.66 (+1.85%)Earnings
- Medivir AB to Discuss Update on the Progress and Plans for the MIV-818 Program Call TranscriptSep 16, 2021
- Q2 2021 Medivir AB Earnings Call TranscriptAug 19, 2021kr8.47 (-4.26%)Earnings
- Q1 2021 Medivir AB Earnings Call TranscriptApr 28, 2021kr6.55 (+1.27%)Earnings
- Q4 2020 Medivir AB Earnings Call TranscriptFeb 26, 2021kr6.88 (+0.84%)Earnings
- Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call TranscriptJan 12, 2021
- Q3 2020 Medivir AB Earnings Call TranscriptNov 10, 2020kr9.15 (-0.73%)Earnings
- Q2 2020 Medivir AB Earnings Call TranscriptAug 20, 2020kr9.55 (+1.57%)Earnings
- Q1 2020 Medivir AB Earnings Call TranscriptMay 05, 2020kr10.05 (-4.96%)Earnings
- Medivir AB R&D Day TranscriptMar 02, 2020
- Q4 2019 Medivir AB Earnings Call TranscriptFeb 13, 2020kr9.74 (-0.14%)Earnings
- Q3 2019 Medivir AB Earnings Call TranscriptNov 27, 2019kr14.77 (+2.09%)Earnings
- Q2 2019 Medivir AB Earnings Call TranscriptAug 28, 2019kr16.15 (-1.64%)Earnings
- Medivir AB to Discuss the Development of Phase IA Study with MIV-818 Call TranscriptJun 13, 2019
- Q1 2019 Medivir AB Earnings Call TranscriptMay 03, 2019kr11.95 (+2.19%)Earnings
Q1 2020 Medivir AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Medivir AB Q1 report 2020. (Operator Instructions) Today, I'm pleased to present Uli Hacksell, CEO. Please begin.
()- -
Thank you so much, and welcome to our Medivir's Q1 2020 report. With me, I have our CFO and our Chief Medical Officer as well.
So let me start by moving to Slide 3, and Magnus, perhaps you can talk about this.
()-
Yes. Thank you, Uli. Yes, please see Slide 3, where you can see the financial summary for quarter 1 in 2020 compared to quarter 1 2019. The turnover amounts to around SEK 7 million, which is higher than last year and relates mainly to the business deal that we signed in the quarter as well as royalty income from Xerclear. And as you can see, the loss before tax has improved significantly in the quarter compared to last year and amount to minus SEK 23 million, compared to SEK
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)